Essex Bio-Technology Ltd.

Essex Bio‑Technology Ltd. develops and markets a diverse biologics pipeline—from ophthalmic FGF drugs and phase‑3 SkQ1, bevacizumab to surgical dermis and dental implants—across China and global markets, supported by key licensing deals.

Headquarters: China (CHN)

Essex Bio-Technology Ltd. Logo
Company Profile
  • Employees: 1,426
  • HQ: Zhuhai
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
1061 Essex Bio-Technology Ltd.
Cap: 2.3B | P/E: 7.5
EQUITY HKG HKD KYG312371035 Active
📈
Home Login